Plain-English translation of NCT05089149 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The CHF-COV study is looking for early warning signs that predict which heart failure patients are at risk of hospitalization or serious complications. Researchers will use a combination of physical exams, blood tests, and ultrasound images to identify markers of fluid buildup (congestion) in the heart, lungs, and other organs. By finding these signs during routine visits, doctors hope to catch problems earlier and prevent hospitalizations.
Fluid buildup is the main reason heart failure patients end up in the hospital, and it often develops without obvious symptoms. This study exists to find reliable early warning signs so doctors can identify at-risk patients before they become seriously ill and need emergency care.
You likely qualify if…
You likely don't qualify if…
During your hospital visit or consultation, you will have a focused physical exam that checks for signs of fluid buildup, along with ultrasound images of your heart, lungs, and blood vessels. You will also have blood drawn for testing and to build a research sample collection. After your visit, the research team will call you periodically over the next 24 months to follow up on your health and any hospitalizations.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France